New imaging agents could show tumors earlier

10/9/2011 | ScienceDaily

Recent research identified new PET scan imaging compounds that detect inflammation and tumors. The agents are derived from cyclooxygenase-2 (COX-2) enzyme inhibitors, and since COX-2 is not in most normal tissues and is present in tumors and inflammatory lesions, it is a useful tool for imaging. "As a tumor grows and becomes increasingly malignant, COX-2 levels go up," said Lawrence Marnett, Ph.D., director of the Vanderbilt Institute of Chemical Biology.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN